Arcadia Biosciences Inc
RKDA
Get informed when a big investor buys or sells
+ FollowMarket Cap$667.05K
Close$
$5.03
1066.9% upside
Current Fair Value
1066.9% upsideUndervalued by 1066.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $667,048.00 |
|---|---|
| Enterprise Value | $-3,510,952.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.71 |
| Beta | 0.53 |
| Outstanding Shares | 1,368,057 |
Return
| Return on Equity | -1758.45% |
|---|---|
| Return on Assets | -188.89% |
| Return on Invested Capital | 93.62% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | -0.13 |
| Price to Sales | 0.14 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.74 |
| Enterprise Value to EBIT | -0.88 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.56
Average shareholder expectationRevenue Estimate
$1.90 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
$2.40 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.46%▼ 10.08% |
|---|---|
| Total Invested | $145,768▼ 69.77% |
| Investors Holding | 16▲ 1.00% |
ESG Score
No data